Search alternatives:
decreases disease » diseases disease (Expand search), decreases adipose (Expand search), decreases breast (Expand search)
not decreases » not decrease (Expand search), not decreased (Expand search), nfoh decreases (Expand search)
decrease not » decrease of (Expand search), decrease akt (Expand search), decrease or (Expand search)
decrease at » decrease akt (Expand search), decrease and (Expand search), decrease in (Expand search)
at decrease » rate decrease (Expand search), that decrease (Expand search), and decrease (Expand search)
decrease to » decreased to (Expand search), decrease toc (Expand search), decrease the (Expand search)
to improved » to improve (Expand search), an improved (Expand search), _ improved (Expand search)
decreases disease » diseases disease (Expand search), decreases adipose (Expand search), decreases breast (Expand search)
not decreases » not decrease (Expand search), not decreased (Expand search), nfoh decreases (Expand search)
decrease not » decrease of (Expand search), decrease akt (Expand search), decrease or (Expand search)
decrease at » decrease akt (Expand search), decrease and (Expand search), decrease in (Expand search)
at decrease » rate decrease (Expand search), that decrease (Expand search), and decrease (Expand search)
decrease to » decreased to (Expand search), decrease toc (Expand search), decrease the (Expand search)
to improved » to improve (Expand search), an improved (Expand search), _ improved (Expand search)
1
2
“.... In this study, the effects of MLT and DHA, combined or not, on PNT1A cells with regard to mitochondria...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
3
4
5
“...Parkinson’s disease (PD) is the most common movement disorder and the second most common...”
Access document
Access document
6
7
8
“... demographic factors predictive of gait and FOG outcomes after STN-DBS are not well established. Managing...”
Access document
Access document
9
10
11
12
13
14
15
16
17
18
19
“... functional and anatomical outcomes after monthly intravitreal bevacizumab for the treatment of macular edema...”
Access document
Access document
Article
20